-transparent.png){kind=logo}
Oral administration of metergoline, an antiserotoninergic agent, produced a fall in plasma prolactin concentrations in normal subjects. Prolactin values remained suppressed during a five day course of treatment with the drug. Serum growth hormone values were not altered significantly.
Related Publications
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
February 1987,
The Journal of reproductive medicine,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
January 1979,
Neuroendocrinology,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
January 1991,
Psychopharmacology,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
October 1977,
Acta endocrinologica,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
September 1980,
British journal of pharmacology,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
January 1980,
Journal of endocrinological investigation,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
July 1971,
Endocrinology,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
August 1991,
Endocrinology,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
January 1977,
Acta endocrinologica,
G Delitala, and
A Masala, and
S Alagna, and
L Devilla, and
P P Rovasio
January 1978,
Journal of endocrinological investigation,
